CEO Interview Allergan

Cramer welcomed David Pyott, Chairman and CEO of Allergan (AGN) to the show to discuss his company’s prospects. “Allergan beat consensus estimates in both sales and earnings per share and blew out the numbers in R&D spending by 32%,” said Poytt. He explained that despite the slow Botox sales in the U.S., the company is growing sales for Botox abroad. He said Botox Cosmetic is a small part of the company’s portfolio of products - 10% of Allergan’s total sales come from Botox. Cramer advised investors to buy this stock at $52 because its too cheap and the analysts are too negative.
…
Fuente Original

  7 May, 2008| Economy | @ 18:11

• VIDEOS
• Economía Blogosfera
• Bitácora
• Economía G . Medios
• Blog de Economía
• Blog Vivienda
• Mercado Divisas
• Agregador Marketing
• El Intercambiador
• Energía, M. Ambiente
• Blog Análisis Técnico
• Canal solidario
• Agregador A.Técnico
• Agregador Motor

• Economy Blogs
• Hedge Funds
• Fundamental Analysis
• Housing Blogs
• Technical Analysis
• Energy Blogs
• Derivatives: Futures
• Marketing Blogs
• Economy Mass Media
• VIDEOS

Categories:

• Economy

Recent Comments

• Daniel: “Kristen,” Ken Stiffed...
• Merfilin: Facebook Cleanup Possible and a Smart ‘Open Web’ Move...
• ArreniaEncani: Time For Yahoo! (YHOO) Board To Wave White Flag...
• studentyahoo: Top 10 Most Searched Stocks on TheStreet.com, Mar. 7...
• Fortino: RevResponse...
• admin: Google and the Aura of Invincibility...

Calendar: